Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


RESMED INC   FYE=6 (June)

Annual - Income Statement - Company Specific

Fiscal period2018201720162015201420132012201120102009
Period End Date6/30/20186/30/20176/30/20166/30/20156/30/20146/30/20136/30/20126/30/20116/30/20106/30/2009
Revenues2,340.202,066.741,838.711,678.911,554.971,514.461,368.521,243.151,092.36920.74
Total Revenues2,340.202,066.741,838.711,678.911,554.971,514.461,368.521,243.151,092.36920.74
Cost of sales978.03864.99772.22667.52565.19573.80547.78501.82436.87366.93
Voluntary product recall expenses--------------------
Gross Profit1,362.161,201.751,066.501,011.40989.79940.66820.74741.33655.48553.80
Amortization of acquired intangible assets46.3846.5823.928.679.7310.1413.9710.158.047.06
Research and development155.15144.47118.65114.87118.23120.12109.7392.0175.2063.06
Education, research and settlement charge----------24.77--------
In-process research and development charge (note 20)--------------------
Selling, general and administrative600.37553.97488.06478.63450.41430.80402.62372.25328.86289.88
Restructuring expenses18.4312.366.91--6.33----------
Donations to Research Foundations----------------(3.00)(3.50)
Acquisition expenses--(10.08)----------------
Litigation settlement expenses--(8.50)----------------
Total Operating Expenses820.33775.95637.55602.16584.70585.83526.33474.40415.10363.49
Operating Income (Loss)541.83425.80428.95409.24405.09354.82294.41266.92240.38190.31
Interest expense28.3628.2411.215.786.136.394.791.762.67--
Interest income (expense), net16.3817.0916.8626.2131.2438.8733.8727.8016.7010.21
Other, net(8.54)4.104.966.250.88(2.19)8.4610.746.181.17
Gain (loss) on extinguishment of debt--------------------
Government grants--------------------
Other: License fees--------------------
Other: Gain/(loss) on foreign currency hedging position------------------2.39
Other: Gain/(loss) on foreign currency transactions----------------6.98--
Other: Other----------------(0.55)0.26
Other: Realized gain on sale of marketable securities--------------------
Other: Impairment of cost method investment----------------(0.25)(1.31)
Other: Gain on sale of real property--------------------
Other: Gain on sale of plant and equipment--------------------
Other: Gain on sale of business assets and contracts----------------0.00(0.18)
Total other income (expenses), net----------------20.2111.37
Pre-Tax Income - U.S42.63(4.99)1.7911.43------(1.42)(17.04)(13.76)
Non-U.S478.69423.73437.78424.49------305.13277.63215.44
Income before Income taxes521.31418.74439.57435.92431.08385.12331.95303.71260.59201.68
Current: Federal128.9716.4724.3328.4318.9342,065.00--10.468.354.13
Current: State0.95(1.16)5.810.701.33888.002.161.441.561.39
Deferred: Federal9.4911.395.64(4.27)(0.42)(1,345.00)(0.35)0.222.05(10.28)
Deferred: State(0.35)2.71(1.64)(0.18)(0.08)(264.00)(0.18)(0.23)(0.18)(0.77)
Current- Non-U.S68.8665.6158.0250.8955.6853,713.0071.3561.4757.2776.38
Deferred- Non-U.S(2.19)(18.55)(4.99)7.4610.37(17,071.00)(12.09)3.371.45(15.62)
Income taxes205.7276.4687.1683.0385.8177.9977.1076.7270.5055.24
Net Income (Loss) Available to Common Shareholders315.59342.28352.41352.89345.27307.13254.85226.99190.09146.45
Continuing Operations- (Basic)----------------1.26--
Basic Earnings Per Share2.212.422.512.512.442.151.751.491.260.97
Continuing Operations- (Diluted)----------------1.23--
Diluted Earnings Per Share2.192.402.492.472.392.101.711.441.230.95
Weighted Average Shares Outstanding (Basic)142.76141.36140.24140.47141.47142.95145.90152.47150.91151.26
Weighted Average Shares Outstanding (Diluted)143.99142.45141.67142.69144.36146.41149.32157.20155.10154.23